New Catheter for Hydrocephalus Shunt Seeking FDA Approval

Tags: , , ,

Alcyone Lifesciences is seeking FDA approval for the commercial resale of a new device to treat hydrocephalus. The ReFlow shunt system is comprised of a flusher, intended to keep the catheter unblocked, with a ventricular catheter and what it calls a “relief membrane.” This device has been successfully implanted in 4 patients in an ongoing study at Boston Children’s Hospital.

Click here to read the full article.

There are no comments published yet.

Leave a Comment

Change this in Theme Options
Change this in Theme Options